Preclinical News and Research

RSS
Tensha raises $15 million in Series A financing to advance bromodomains for cancer

Tensha raises $15 million in Series A financing to advance bromodomains for cancer

Spinifex announces new data from EMA401 pre-clinical study on diabetic neuropathy

Spinifex announces new data from EMA401 pre-clinical study on diabetic neuropathy

Diamyd receives NIH grant to develop NTDDS for Chemotherapy Induced Peripheral Neuropathy

Diamyd receives NIH grant to develop NTDDS for Chemotherapy Induced Peripheral Neuropathy

New treatment strategy for dominant forms of muscular dystrophy

New treatment strategy for dominant forms of muscular dystrophy

InnoCentive, JDRF announce $100,000 Challenge to uncover solutions for insulin-dependent diabetes

InnoCentive, JDRF announce $100,000 Challenge to uncover solutions for insulin-dependent diabetes

Aura's NanoSmart platform can enable earlier detection, treatment of cancers

Aura's NanoSmart platform can enable earlier detection, treatment of cancers

Sagene completes SPI-1972 pre-IND meeting with FDA for erectile dysfunction

Sagene completes SPI-1972 pre-IND meeting with FDA for erectile dysfunction

Positive results from Sanaria PfSPZ Vaccine initial Phase 1 trial on malaria

Positive results from Sanaria PfSPZ Vaccine initial Phase 1 trial on malaria

Bristol-Myers Squibb acquires Amira Pharmaceuticals

Bristol-Myers Squibb acquires Amira Pharmaceuticals

'Chaperone' protein may play a critical role in pathogenesis of heart failure

'Chaperone' protein may play a critical role in pathogenesis of heart failure

Researchers identify new drug target for heart failure

Researchers identify new drug target for heart failure

ATA announces five recipients of 2011 thyroid cancer research grants

ATA announces five recipients of 2011 thyroid cancer research grants

Developing technologies to improve treatment of craniosynostosis in babies

Developing technologies to improve treatment of craniosynostosis in babies

Ardea Biosciences reports positive outcome from lesinurad End-of-Phase 2 meetings with FDA

Ardea Biosciences reports positive outcome from lesinurad End-of-Phase 2 meetings with FDA

Loss of estrogen receptor alpha protein may lead to metabolic syndrome

Loss of estrogen receptor alpha protein may lead to metabolic syndrome

BioLineRx, Tel Aviv University sign license agreement to develop and commercialize BL-7050

BioLineRx, Tel Aviv University sign license agreement to develop and commercialize BL-7050

International researchers to assess role of pre-clinical animal models in drug discovery

International researchers to assess role of pre-clinical animal models in drug discovery

Leading cancer journals publish OncoGenex's custirsen pre-clinical and Phase II study data

Leading cancer journals publish OncoGenex's custirsen pre-clinical and Phase II study data

Researchers use ultrasound to improve quality of blood stem cell transplant

Researchers use ultrasound to improve quality of blood stem cell transplant

Discovery Labs files Complete Response to FDA for SURFAXIN to treat RDS in premature infants

Discovery Labs files Complete Response to FDA for SURFAXIN to treat RDS in premature infants

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.